Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515
Benzinga Newsdesk 3 months ago
NewsDowngradesAnalyst RatingsPrice Target
Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.
Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.